Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background: Optimal interventions to prevent or delay cognitive decline, mild cognitive impairment (MCI), or dementia are uncertain. Purpose: To summarize the evidence on efficacy and harms of over-the-counter (OTC) supplements to prevent or delay cognitive decline, MCI, or clinical Alzheimer-type dementia in adults with normal cognition or MCI but no dementia diagnosis. Data Sources: Multiple electronic databases from 2009 to July 2017 and bibliographies of systematic reviews. Study Selection: English-language trials of at least 6 months' duration that enrolled adults without dementia and compared cognitive outcomes with an OTC supplement versus placebo or active controls. Data Extraction: Extraction performed by a single reviewer and confirmed by a second reviewer; dual-reviewer assessment of risk of bias; consensus determination of strength of evidence. Data Synthesis: Thirty-eight trials with low to medium risk of bias compared ω-3 fatty acids, soy, ginkgo biloba, B vitamins, vitamin D plus calcium, vitamin C or β-carotene, multi-ingredient supplements, or other OTC interventions with placebo or other supplements. Few studies examined effects on clinical Alzheimer-type dementia or MCI, and those that did suggested no benefit. Daily folic acid plus vitamin B12 was associated with improvements in performance on some objectively measured memory tests that were statistically significant but of questionable clinical significance. Moderate-strength evidence showed that vitamin E had no benefit on cognition. Evidence about effects of ω-3 fatty acids, soy, ginkgo biloba, folic acid alone or with other B vitamins, β-carotene, vitamin C, vitamin D plus calcium, and multivitamins or multi-ingredient supplements was either insufficient or low-strength, suggesting that these supplements did not reduce risk for cognitive decline. Adverse events were rarely reported. Limitation: Studies had high attrition and short follow-up and used a highly variable set of cognitive outcome measures. Conclusion: Evidence is insufficient to recommend any OTC supplement for cognitive protection in adults with normal cognition or MCI. Primary Funding Source: Agency for Healthcare Research and Quality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review of the use of supplements, including vitamins C, D and E, omega-3 fatty acids and ginkgo biloba, found little to no benefit in preventing cognitive decline, MCI or Alzheimer's dementia.138”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [138]
In the citing paper
“No single food, beverage, ingredient, vitamin or supplement has been proven to prevent or cure Alzheimer's or any other dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [146]
Citations
Cites
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758 · cited 1×
“8 mg) compared with placebo over 3 years (31).”
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 670
Qato, D. M., Wilder, J., Schumm, L. P., Gillet, V., & Alexander, G. C. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8581 · Cited by 658
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Beneficial effects of docosahexaenoic acid on cognition in age‐related cognitive decline
Yurko‐Mauro, K., McCarthy, D., Rom, D., Nelson, E. B., Ryan, A. S., Blackwell, A., Salem, N., Stedman, M., & MIDAS Investigators (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.01.013 · Cited by 579 · cited 5×
“One study used only docosahexaenoic acid (DHA) (17); all others used some combination of eicosapentaenoic acid (EPA) plus DHA.”
InfluentialPreventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment
Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R., E. Nichols, T., Smith, S. M., & Smith, A. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301816110 · Cited by 515
de Jager, C. A., Oulhaj, A., Jacoby, R., Refsum, H., & Smith, A. D. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2758 · Cited by 457
Research works printed but not linked: 1
- Charemboon T, 2015, J Med Assoc Thai, 98, 508
Cited by
Items 101–144 of 144
Khaled, M., Al-Jamal, H., Tajer, L., & El-Mir, R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231432 · Cited by 4
“However, a thorough analysis of the short-term effect of using supplements containing vitamins C, D, and E, omega-3, and Ginkgo biloba, revealed little to no benefit in preventing cognitive decline, MCI, or AD [144].”
McLimans, K. E., Martinez, A. D. C., Mochel, J. P., Allenspach, K., & Willette, A. A. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520000951 · Cited by 4
“Vitamin B12 combined with folate does appear to havemodest clinical efficacy in CNorMCI participants, however(18).”
Neurorehabilitation and Physical Therapy
Nakano, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102185 · Cited by 5
Accuracy of the Cognitive Assessment Battery in a Primary Care Population
Segernäs, A., Johansson, M. M., & Marcusson, J. O. (2019) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000501365 · Cited by 4
Musigavong, N., Boonyarat, C., Chulikhit, Y., Monthakantirat, O., Limudomporn, M., Pitiporn, S., Kwankhao, P., & Daodee, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1148112 · Cited by 4
“At present, there is no approval for over-the-counter supplements or drugs to prevent or treat mild cognitive impairment [17].”
BackgroundUpdate on Treatments for Cognitive Decline in Alzheimer’s Disease
Kriebel-Gasparro, A. M. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2019.12.016 · Cited by 4
Online Promotion of “Brain Health” Supplements
Block, B. R., Albanese, S. G., & Hume, A. L. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.489 · Cited by 3
Dietary Supplements for Brain Health—Reply
Hellmuth, J. M., Rabinovici, G. D., & Miller, B. L. (2019) · JAMA · doi:10.1001/jama.2019.4967 · Cited by 3
Musich, M. L., Shenker, J. I., & Beversdorf, D. Q. (2026) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad3010004 · Cited by 2
Dorman, G. S., Flores, I., Gutiérrez, C., Castaño, R. F., Aldecoa, M., & Kim, L. M. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210809121230 · Cited by 3
Brain Health Attitudes, Awareness and Actions in Middle-Aged Latinos
Weiner‐Light, S., Hurtado, J., del Salto, M., Opsasnick, L. A., Batio, S., VELA, A. M., Sideman, A. B., & Wolf, M. S. (2025) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-025-01677-y · Cited by 2
“This is consistent with prior work [13] and may represent a potential vulnerability to unproven ‘anti-aging’ products, as little to no benefit has been found from these treatments [55 ].”
Okumiyama, H., Tsuboi, Y., Fujii, R., Iwahara, A., Hatta, T., Sato, S., Yamada, H., & Suzuki, K. A. O. (2025) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.25-00090 · Cited by 2
“A recent systematic review focusing on the e ff ects of interventions using ¢ - carotene supplements found no signi fi cant evidence regarding a role in preventing cognitive decline [27].”
Hussain, S. A., Abdulrahman, Z. S., & Mustafa, W. W. (2022) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2345 · Cited by 3
Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s Disease
Dominguez, L. J., & Barbagallo, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815238-6.00015-8 · Cited by 4
The omega-3 index in Alzheimer’s disease: Ready for prime time?
Yassine, H. N. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac248 · Cited by 3
“To date, findings from trials investigating the effects of ω-3 supplementation on cognitive outcomes have not been compelling (4).”
BackgroundGao, Z., Luo, T., Ye, C., Cheng, K., Qian, L., Cai, Q., Zhou, Q., Fang, H., Zhang, G., Cai, S., et al. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283848 · Cited by 2
Association between vitamin D supplement use and cognitive functioning: a longitudinal cohort study
Hua, R., Lam, C. S., Mok, V., & Cheung, Y. T. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-106050 · Cited by 1
Phytological facets of extant maidenhair: Gingko biloba Linn
Khan, T. A., Arshad, M. R., & Ikram, M. H. (2024) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2024.12.00424 · Cited by 1
Geriatrics update 2018: Challenges in mental health, mobility, and postdischarge care
Kim, L. D., & Hashmi, A. Z. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85a.18059 · Cited by 1
Antioxidants and risk of dementia: recent insights and future opportunities
Koch, M., Dhana, K., & Jensen, M. K. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000544 · Cited by 1
Understanding the relationship between oxidative stress and cognition in the elderly
Perry, N., Martin, L., Rosenfeldt, F., Ou, R., Rowsell, R., & Stough, C. K. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00006-9 · Cited by 2
Dietary Supplements for Brain Health
Smith, A. D., Refsum, H., & Miller, J. W. (2019) · JAMA · doi:10.1001/jama.2019.4963 · Cited by 1
Many Methods to Prevent Cognitive Decline Fall Short
Molano, J. R. V. (2018) · Journal watch · doi:10.1056/nejm-jw.na45755
No ‘magic bullet’ for preventing cognitive decline, study suggests
Bonner, L. (2018) · Pharmacy Today · doi:10.1016/j.ptdy.2018.02.023
Dietary Botanicals and Supplements
Remde, A., & Teets, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-19625-7_15
The Role of Nutrition in Cognitive Decline
Rahi, B., Raji, C. A., Meysami, S., & Merrill, D. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108552684.038
Anderson, S. E. (2021) · Account and Financial Management Journal · doi:10.47191/afmj/v6i10.02
Anderson, S. E. (2021) · Account and Financial Management Journal · doi:10.47191/afmj/v6i7.03
Exercise Convergence Science for the Treatment of Mild Cognitive Impairment
Lee, J.-E., & Lee, H.-S. (2022) · Exercise Science · doi:10.15857/ksep.2022.00563
Bienenfeld, D., & Dienstag, A. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_72-1
Bienenfeld, D., & Dienstag, A. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_72-2
Özcan, Ö. Ö., Karahan, M., & Konuk, M. (2023) · Food bioactive ingredients · doi:10.1007/978-3-031-41188-5_10
Antioxidant supplements as a means to prevent Alzheimer’s disease following COVID-19 infection
Hosseini, M., & Farrokhi, M. R. (2023) · Aktualności Neurologiczne · doi:10.15557/an.2023.0007
Bienenfeld, D., & Dienstag, A. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_72
Best Practices for Communicating Nutrition and Brain Health Science
Roberson, L. B., Latulippe, M. E., Ohlhorst, S. D., Faye, D., Aarts, K., Steiber, A. L., Ferland, G., Coetzee, T., Chura, L. R., & Ho, E. H. (2025) · Nutrition Today · doi:10.1097/nt.0000000000000744
Zhou, S., Schutte, D., Xing, A., Chen, J., Wolfson, J. A., He, Z., Yu, F., & Zhang, R. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03252-9
“For example, the strength of evidence of ω-3 fatty acids, soy, ginkgo biloba, folic acid alone or with other B vitamins, β-carotene, vitamin C, vitamin D plus calcium, and multivitamins or multi-ingredient supplements on reducing cognitive decline or ADRD was insufficient, low, or none [7, 12, 13].”
What Happens to the Brain When We Age?
Biesalski, H. K. (2025) · Springer eBooks · doi:10.1007/978-3-031-99121-9_14
Weiner‐Light, S., Tomasino, F., del Salto, M., VELA, A. M., Wolf, M. S., & Sideman, A. B. (2025) · Ethnicity and Health · doi:10.1080/13557858.2025.2600276
“Messaging might highlight that current evidence suggests weak correlations between vitamins/supplements and preventing cognitive decline (Butler et al. 2018; Livingston et al. 2024).”
Lefèvre‐Arbogast, S. (2019) · theses.fr (ABES) · doi:10.70675/6915e632z663fz4caaz9c7az455ad25755da
Huang, Y., Li, Q., Chen, A., Li, Y., Chuang, Y.-N., Hu, X., Guo, S. J., He, X., Pang, Y., Zhou, J., et al. (2026) · JAMIA Open · doi:10.1093/jamiaopen/ooag060 · Cited by 2
Wang, X., Jiang, S., Zou, T., Shang, S., Zhang, E., Rong, L., & Fang, Q. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1775177
“Current pharmacological treatments for MCI, such as cholinesterase inhibitors and memantine, have shown limited effectiveness in delaying disease progression and are frequently associated with adverse effects, which contribute to poor patient adherence (6).”
Wang, Y., Qin, Q., Yang, K., Yu, M., Yao, Y., Gong, C., Guo, J. Z., Yang, L., & Tang, Y. (2026) · medRxiv · doi:10.64898/2026.04.30.26352138
Wang, Y., Qin, Q., Yang, K., Yu, M., Yao, Y., Gong, C., Guo, J., Yang, L., & Tang, Y. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-122035
Metadata
- Authors
- Butler, M., Nelson, V. A., Davila, H., Ratner, E., Fink, H. A., Hemmy, L. S., McCarten, J. R., Barclay, T. R., Brasure, M., & Kane, R. L.
- Affiliations
- University of Minnesota (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2018-01-02
- Volume
- 168
- Issue
- 1
- Pages
- 52-62
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2778293650
- Cited by
- 144
- References
- 52
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 17 · 2023: 16 · 2022: 17 · 2021: 25 · 2020: 20 · 2019: 21 · 2018: 11
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- over-the-counter supplements, cognitive decline, mild cognitive impairment, Alzheimer-type dementia, dementia prevention, omega-3 fatty acids, soybean, Ginkgo biloba, B vitamins, folic acid, vitamin B12, vitamin E, beta-carotene, vitamin C, multivitamins, memory, adverse events
- MeSH terms
- Alzheimer Disease, Nonprescription Drugs, Humans, Dietary Supplements, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.